Literature DB >> 28024302

Readmission Rates After Passage of the Hospital Readmissions Reduction Program: A Pre-Post Analysis.

Jason H Wasfy1, Corwin Matthew Zigler1, Christine Choirat1, Yun Wang1, Francesca Dominici1, Robert W Yeh1.   

Abstract

BACKGROUND: Whether hospitals with the highest risk-standardized readmission rates (RSRRs) subsequently experienced the greatest improvement after passage of the Medicare Hospital Readmissions Reduction Program (HRRP) is unknown.
OBJECTIVE: To evaluate whether passage of the HRRP was followed by acceleration in improvement in 30-day RSRRs after hospitalizations for acute myocardial infarction (AMI), congestive heart failure (CHF), or pneumonia and whether the lowest-performing hospitals had faster acceleration in improvement after passage of the law than hospitals that were already performing well.
DESIGN: Pre-post analysis stratified by hospital performance groups.
SETTING: U.S. acute care hospitals. PATIENTS: 15 170 008 Medicare patients discharged alive from 2000 to 2013. INTERVENTION: Passage of the HRRP. MEASUREMENTS: 30-day readmission rates after hospitalization for AMI, CHF, or pneumonia for hospitals in the highest-performance (0% penalty), average-performance (>0% and <0.50% penalty), low-performance (≥0.50% and <0.99% penalty), and lowest-performance (≥0.99% penalty) groups.
RESULTS: Of 2868 hospitals serving 1 109 530 Medicare discharges annually, 30.1% were highest performers, 44.0% were average performers, 16.8% were low performers, and 9.0% were lowest performers. After controlling for prelaw trends, an additional 67.6 (95% CI, 66.6 to 68.4), 74.8 (CI, 74.0 to 75.4), 85.4 (CI, 84.0 to 86.8), and 95.1 (CI, 92.6 to 97.5) readmissions per 10 000 discharges were found to have been averted per year in the highest-, average-, low-, and lowest-performance groups, respectively, after passage of the law. LIMITATION: Inability to distinguish between improvement caused by the magnitude of the penalty or by different levels of health improvement in different patient populations.
CONCLUSION: After passage of the HRRP, 30-day RSRRs for myocardial infarction, heart failure, and pneumonia decreased more rapidly than before the law's passage. Improvement was most marked for hospitals with the lowest prelaw performance. PRIMARY FUNDING SOURCE: National Institutes of Health.

Entities:  

Mesh:

Year:  2016        PMID: 28024302      PMCID: PMC5507076          DOI: 10.7326/M16-0185

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Thirty-day readmissions--truth and consequences.

Authors:  Karen E Joynt; Ashish K Jha
Journal:  N Engl J Med       Date:  2012-03-28       Impact factor: 91.245

2.  Medicare's readmissions-reduction program--a positive alternative.

Authors:  Robert A Berenson; Ronald A Paulus; Noah S Kalman
Journal:  N Engl J Med       Date:  2012-03-28       Impact factor: 91.245

3.  Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project.

Authors:  Saif S Rathore; Frederick A Masoudi; Yongfei Wang; Jeptha P Curtis; JoAnne M Foody; Edward P Havranek; Harlan M Krumholz
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

4.  Behavioral economics and physician compensation--promise and challenges.

Authors:  Dhruv Khullar; Dave A Chokshi; Robert Kocher; Ashok Reddy; Karna Basu; Patrick H Conway; Rahul Rajkumar
Journal:  N Engl J Med       Date:  2015-06-11       Impact factor: 91.245

5.  Comprehensive smoking bans and acute myocardial infarction among Medicare enrollees in 387 US counties: 1999-2008.

Authors:  Christopher D Barr; David M Diez; Yun Wang; Francesca Dominici; Jonathan M Samet
Journal:  Am J Epidemiol       Date:  2012-09-17       Impact factor: 4.897

6.  The long-term effect of premier pay for performance on patient outcomes.

Authors:  Ashish K Jha; Karen E Joynt; E John Orav; Arnold M Epstein
Journal:  N Engl J Med       Date:  2012-03-28       Impact factor: 91.245

7.  An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction.

Authors:  Harlan M Krumholz; Yun Wang; Jennifer A Mattera; Yongfei Wang; Lein Fang Han; Melvin J Ingber; Sheila Roman; Sharon-Lise T Normand
Journal:  Circulation       Date:  2006-03-20       Impact factor: 29.690

8.  Analysis of longitudinal data to evaluate a policy change.

Authors:  Benjamin French; Patrick J Heagerty
Journal:  Stat Med       Date:  2008-10-30       Impact factor: 2.373

9.  Long-term effect of hospital pay for performance on mortality in England.

Authors:  Søren Rud Kristensen; Rachel Meacock; Alex J Turner; Ruth Boaden; Ruth McDonald; Martin Roland; Matthew Sutton
Journal:  N Engl J Med       Date:  2014-08-07       Impact factor: 91.245

10.  Reduced mortality with hospital pay for performance in England.

Authors:  Matt Sutton; Silviya Nikolova; Ruth Boaden; Helen Lester; Ruth McDonald; Martin Roland
Journal:  N Engl J Med       Date:  2012-11-08       Impact factor: 91.245

View more
  53 in total

1.  Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States.

Authors:  Marc D Samsky; Andrew P Ambrosy; Erik Youngson; Li Liang; Padma Kaul; Adrian F Hernandez; Eric D Peterson; Finlay A McAlister
Journal:  JAMA Cardiol       Date:  2019-05-01       Impact factor: 14.676

2.  Patient Readmission Rates For All Insurance Types After Implementation Of The Hospital Readmissions Reduction Program.

Authors:  Enrico G Ferro; Eric A Secemsky; Rishi K Wadhera; Eunhee Choi; Jordan B Strom; Jason H Wasfy; Yun Wang; Changyu Shen; Robert W Yeh
Journal:  Health Aff (Millwood)       Date:  2019-04       Impact factor: 6.301

3.  Hospital Readmission Rates in Medicare Advantage and Traditional Medicare: A Retrospective Population-Based Analysis.

Authors:  Orestis A Panagiotou; Amit Kumar; Roee Gutman; Laura M Keohane; Maricruz Rivera-Hernandez; Momotazur Rahman; Pedro L Gozalo; Vincent Mor; Amal N Trivedi
Journal:  Ann Intern Med       Date:  2019-06-25       Impact factor: 25.391

4.  Longitudinal trajectories of hospital performance across targeted cardiovascular conditions in the USA.

Authors:  Muthiah Vaduganathan; Cian P McCarthy; Colby Ayers; Deepak L Bhatt; Dharam J Kumbhani; James A de Lemos; Gregg C Fonarow; Ambarish Pandey
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2020-01-01

Review 5.  Elements of Program Design in Medicare's Value-based and Alternative Payment Models: a Narrative Review.

Authors:  Karen E Joynt Maddox; Aditi P Sen; Lok Wong Samson; Rachael B Zuckerman; Nancy DeLew; Arnold M Epstein
Journal:  J Gen Intern Med       Date:  2017-07-17       Impact factor: 5.128

6.  Aligning innovations in health funding with innovations in care.

Authors:  Noah M Ivers; Irfan Dhalla; Adalsteinn Brown
Journal:  CMAJ       Date:  2018-08-13       Impact factor: 8.262

7.  Hospital Readmissions Reduction Program and Post-Acute Care: Implications for Service Delivery and 30-Day Hospital Readmission.

Authors:  Chih-Ying Li; Amol Karmarkar; Yu-Li Lin; Yong-Fang Kuo; Kenneth J Ottenbacher
Journal:  J Am Med Dir Assoc       Date:  2020-07-11       Impact factor: 4.669

8.  Association of Rankings With Cardiovascular Outcomes at Top-Ranked Hospitals vs Nonranked Hospitals in the United States.

Authors:  David E Wang; Rishi K Wadhera; Deepak L Bhatt
Journal:  JAMA Cardiol       Date:  2018-12-01       Impact factor: 14.676

9.  Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency.

Authors:  Jason H Wasfy; Kevin F Kennedy; Frederick A Masoudi; Timothy G Ferris; Suzanne V Arnold; Vinay Kini; Pamela Peterson; Jeptha P Curtis; Amit P Amin; Steven M Bradley; William J French; John Messenger; P Michael Ho; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-09

10.  Hospital-Readmission Risk - Isolating Hospital Effects from Patient Effects.

Authors:  Harlan M Krumholz; Kun Wang; Zhenqiu Lin; Kumar Dharmarajan; Leora I Horwitz; Joseph S Ross; Elizabeth E Drye; Susannah M Bernheim; Sharon-Lise T Normand
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.